15 results
Stress Dose Steroids - Indications and Dosing

SUPPRESSED HPA AXIS:
 prednisone >20mg/day x 3 weeks or more
Dose Steroids - Indications ... and Dosing SUPPRESSED ... #Dosing #Endocrinology ... #Diagnosis #Management ... #Pharmacology
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
in Cirrhosis • Pathophysiology ... • Indications: ... gastropathy • Dosing ... hepatology #management #pharmacology ... #indications #dosing
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Common Diabetes Medications ... #Diabetes #Medications ... #pharmacology # ... pathophysiology ... #endocrinology
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
Bisphosphonates are common medications ... are a variety of dosing ... Bisphosphonates #Dosing ... Schedule #Frequency #Pharmacology ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... very tolerable medication ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Diabetes #DM2 #Endocrinology
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
#differential #diagnosis ... #pathophysiology ... #pharmacology # ... potassium #medications
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... mistaken these medications ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Pediatric Parasomnias and Nightmares: Pathogenesis and clinical findings

Parasomnias - Micro-arousal episodes during SWS ->
Intense activation of
Persisting sleep during ... unpleasant dreams during ... Pediatrics #Peds #pathophysiology ... #symptoms #pharmacology ... #diagnosis
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Inhibitors Increasing Indications ... level < 200 mg/dL Pathophysiology ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
Hashitoxicosis

‘Leakage’ symptoms of active Hashimoto’s disease

- Hashitoxicosis (Htx) can occur during the initial hyperthyroid stage in
Htx) can occur during ... Hashitoxicosis #Hashimotos #Endocrinology ... #Diagnosis #Pathophysiology